
{
    "Variants Include": [
        {
            "Gene": "PRKN",
            "variants": [
                {
                    "HGVS": "NM_004562.3:c.718T>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "T",
                        "alt": "C",
                        "position": "718"
                    },
                    "Protein Change": {
                        "ref": "T",
                        "alt": "R",
                        "position": "240"
                    },
                    "Description in input context": "parkinT240R, with a Thrâ†’Arg mutation in RING1 domain"
                },
                {
                    "HGVS": "NM_004562.3:c.124G>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "G",
                        "alt": "C",
                        "position": "124"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "P",
                        "position": "42"
                    },
                    "Description in input context": "parkinR42P, with a mutation in Ubl-domain"
                },
                {
                    "HGVS": "NM_004562.3:c.931C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "931"
                    },
                    "Protein Change": {
                        "ref": "Q",
                        "alt": "X",
                        "position": "311"
                    },
                    "Description in input context": "parkinQ311stop"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Autosomal recessive juvenile parkinsonism",
        "MONDO": "MONDO:0015448"
    },
    "Experiment Method": [
        {
            "Assay Method": "Co-immunoprecipitation",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "HEK293 cells were used for co-immunoprecipitation experiments."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.718T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "parkinT240R did not associate with UbcH7."
                },
                {
                    "Variant": "NM_004562.3:c.124G>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "parkinR42P was capable of binding UbcH7."
                },
                {
                    "Variant": "NM_004562.3:c.931C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Lysates without Myc-parkin were used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Presence of UbcH7 co-immunoprecipitation with parkin.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Absence of UbcH7 co-immunoprecipitation with parkin.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ubiquitination Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y",
                "Description": "Human dopaminergic neuroblastoma SH-SY5Y cells were used."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.718T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "parkinT240R did not co-immunoprecipitate ubiquitinated protein bands and failed in in vitro ubiquitination assay."
                },
                {
                    "Variant": "NM_004562.3:c.124G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "parkinR42P failed to co-immunoprecipitate ubiquitinated proteins and showed no in vitro ubiquitination activity."
                },
                {
                    "Variant": "NM_004562.3:c.931C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "parkinQ311stop (nonsense mutation) likely results in truncated protein, and its effect on ubiquitination was not explicitly tested but inferred as abnormal due to structural disruption."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "IP-Parkin(SH-SY5Y) from wild-type cells was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "IP-Parkin (HEK293) and mutant parkins without E1/E2 were used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Presence of high molecular weight ubiquitinated protein bands ((Ub)n) and in vitro ubiquitination activity.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Absence of ubiquitinated protein bands and in vitro ubiquitination activity.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Domain Analysis (Co-immunoprecipitation and Ubiquitination Assay)",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293, SH-SY5Y",
                "Description": "HEK293 cells were used for co-immunoprecipitation; SH-SY5Y cells were used for ubiquitination assays."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.718T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "RING1 mutation (T240R) abolished UbcH7 binding and ubiquitination activity."
                },
                {
                    "Variant": "NM_004562.3:c.124G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "Ubl-domain mutation (R42P) allowed UbcH7 binding but failed to recruit ubiquitinated proteins and showed no ubiquitination activity."
                },
                {
                    "Variant": "NM_004562.3:c.931C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "Nonsense mutation (Q311stop) likely truncates protein, disrupting RING-box domain and resulting in loss of UbcH7 binding and ubiquitination activity (inferred from structural requirements)."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin and domain-truncated constructs (e.g., Parkin77-465 retaining RING-box) were used as positive controls for domain function."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Constructs lacking RING-box or Ubl domains (e.g., Parkin with deleted Ubl or RING-box) were used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Functional domain (RING-box for E2 binding, Ubl for substrate recognition) intact and capable of mediating UbcH7 binding/ubiquitination."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Domain disruption leading to loss of UbcH7 binding or ubiquitination activity."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}